By expenditures
| Name | Title | Type |
|---|---|---|
| Evelyn Barnes | Chief Financial Officer | Auditee |
| Richard Bowman | Controller | Auditee |
| Michele Divito | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 351892 | 2024 | 2025-03-31 | Rsm US LLP | $7.91M |
| 299883 | 2023 | 2024-03-28 | Rsm US LLP | $7.59M |
| 24262 | 2022 | 2023-03-30 | Rsm US LLP | $9.49M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 299883 | 2023 | 2024-03-28 | 964290 | 2023-004 | Significant Deficiency | - | C |
| 299883 | 2023 | 2024-03-28 | 964289 | 2023-003 | Significant Deficiency | - | G |
| 299883 | 2023 | 2024-03-28 | 387848 | 2023-004 | Significant Deficiency | - | C |
| 299883 | 2023 | 2024-03-28 | 387847 | 2023-003 | Significant Deficiency | - | G |
| 24262 | 2022 | 2023-03-30 | 606889 | 2022-006 | Significant Deficiency | Yes | I |
| 24262 | 2022 | 2023-03-30 | 606888 | 2022-005 | Material Weakness | - | G |
| 24262 | 2022 | 2023-03-30 | 606887 | 2022-004 | Significant Deficiency | - | C |
| 24262 | 2022 | 2023-03-30 | 606886 | 2022-003 | Significant Deficiency | - | L |
| 24262 | 2022 | 2023-03-30 | 606885 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 606884 | 2022-007 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 606883 | 2022-006 | Significant Deficiency | Yes | I |
| 24262 | 2022 | 2023-03-30 | 606882 | 2022-005 | Material Weakness | - | G |
| 24262 | 2022 | 2023-03-30 | 606881 | 2022-004 | Significant Deficiency | - | C |
| 24262 | 2022 | 2023-03-30 | 606880 | 2022-003 | Significant Deficiency | - | L |
| 24262 | 2022 | 2023-03-30 | 606879 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 606878 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 606877 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 606876 | 2022-010 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 606875 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 606874 | 2022-008 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 30447 | 2022-006 | Significant Deficiency | Yes | I |
| 24262 | 2022 | 2023-03-30 | 30446 | 2022-005 | Material Weakness | - | G |
| 24262 | 2022 | 2023-03-30 | 30445 | 2022-004 | Significant Deficiency | - | C |
| 24262 | 2022 | 2023-03-30 | 30444 | 2022-003 | Significant Deficiency | - | L |
| 24262 | 2022 | 2023-03-30 | 30443 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 30442 | 2022-007 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 30441 | 2022-006 | Significant Deficiency | Yes | I |
| 24262 | 2022 | 2023-03-30 | 30440 | 2022-005 | Material Weakness | - | G |
| 24262 | 2022 | 2023-03-30 | 30439 | 2022-004 | Significant Deficiency | - | C |
| 24262 | 2022 | 2023-03-30 | 30438 | 2022-003 | Significant Deficiency | - | L |
| 24262 | 2022 | 2023-03-30 | 30437 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 30436 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 30435 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 30434 | 2022-010 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 30433 | 2022-009 | Significant Deficiency | - | N |
| 24262 | 2022 | 2023-03-30 | 30432 | 2022-008 | Significant Deficiency | - | N |